Currently out of the existing stock ratings of Ravi Misra, 10 are a BUY (34.48%), 17 are a HOLD (58.62%), 2 are a SELL (6.9%).
Analyst Ravi Misra, currently employed at TRUIST, has had 67.12% of price targets met with an average potential upside of 18.34%, reached in 93 days on average.
Ravi Misra has documented 57 price targets and ratings displayed on 11 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on TFX, Teleflex.
Analyst best performing recommendations are on IART (INTEGRA LIFESCIENCES HOLDINGS).
The best stock recommendation documented was for IART (INTEGRA LIFESCIENCES HOLDINGS) on 7/16/2026. The price target of $19 was fulfilled within 4 days with a profit of $0.85 (4.28%), with a performance score of 10.71.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 21-Oct-2025
$175
$6.68 (3.97%)
$188
17 days ago
(29-Oct-2026)
25/38 (65.79%)
$21.29 (13.85%)
134
Buy Since 25-Mar-2025
$200
$31.68 (18.82%)
$200
24 days ago
(22-Oct-2026)
11/17 (64.71%)
$44.49 (28.61%)
180
Buy Since 01-May-2025
$205
$36.68 (21.79%)
$235
25 days ago
(21-Oct-2026)
17/57 (29.82%)
$53.63 (35.43%)
95
Buy Since 18-Oct-2017
$162
$-6.32 (-3.75%)
$250
1 months ago
(15-Oct-2026)
21/30 (70%)
$12.66 (8.48%)
97
Buy Since 17-Oct-2025
$215
$46.68 (27.73%)
$172
1 months 1 days ago
(14-Oct-2026)
3/5 (60%)
$70.56 (48.85%)
40
Which stock is Ravi Misra most bullish on?
Which stock is Ravi Misra most reserved on?
What Year was the first public recommendation made by Ravi Misra?
